Deciphering the regulatory logic of an ancient, ultraconserved nuclear receptor enhancer module

Molecular Endocrinology

Volumn 29, Issue 6, 2015, Pages 856-872

  Bagamasbad, Pia D ^a   Bonett, Ronald M ^b   Sachs, Laurent ^c   Buisine, Nicolas ^c   Raj, Samhitha ^a   Knoedler, Joseph R ^d   Kyono, Yasuhiro ^d   Ruan, Yijun ^e,f,g   Ruan, Xiaoan ^e,f,g   Denver, Robert J ^a,d  

^a CNRS   (France)

^b UNIVERSITY OF TULSA   (United States)

^c MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^d UNIVERSITY OF MICHIGAN   (United States)

^e GENOME INSTITUTE OF SINGAPORE   (Singapore)

^f The Jackson Laboratory of Genomic Medicine   (Singapore)

^g UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; DNA; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 9; LONG UNTRANSLATED RNA; MESSENGER RNA; PHOSPHOSERINE; RNA POLYMERASE II; SERINE; THYROID HORMONE; UNCLASSIFIED DRUG; CELL RECEPTOR; CHROMATIN; CORTISONE; GLUCOCORTICOID RECEPTOR; HISTONE; LIOTHYRONINE; PROTEIN BINDING;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CHROMATIN; EMBRYO; ENHANCER REGION; GENETIC CONSERVATION; GENETIC TRANSCRIPTION; HORMONAL REGULATION; HORMONE RESPONSE; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION; RNA EXTRACTION; TETRAPOD; TRANSACTIVATION; TRANSCRIPTION INITIATION SITE; TRANSIENT TRANSFECTION; XENOPUS TROPICALIS; ACETYLATION; ANIMAL; BASE PAIRING; BRAIN; C57BL MOUSE; CONSERVED SEQUENCE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE LOCUS; GENE SILENCING; GENETICS; METABOLISM; MOLECULAR EVOLUTION; NUCLEOTIDE SEQUENCE; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION; XENOPUS;

CHORDATA; PHOS; TETRAPODA; VERTEBRATA;

ACETYLATION; ANIMALS; BASE PAIRING; BASE SEQUENCE; BRAIN; CHROMATIN; CONSERVED SEQUENCE; CORTISONE; ENHANCER ELEMENTS, GENETIC; EVOLUTION, MOLECULAR; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GENETIC LOCI; HISTONES; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE, INBRED C57BL; MUTAGENESIS, SITE-DIRECTED; PROTEIN BINDING; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, GLUCOCORTICOID; RNA POLYMERASE II; RNA, LONG NONCODING; RNA, MESSENGER; TRANSCRIPTIONAL ACTIVATION; TRIIODOTHYRONINE; XENOPUS;

EID: 84930863372     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2014-1349     Document Type: Article

References (101)

1. Denver RJ. Stress hormones mediate environment-genotype interactions during amphibian development. Gen Comp Endocrinol. 2009;164:20–31.
2. Bonett RM, Hoopfer ED, Denver RJ. Molecular mechanisms of corticosteroid synergy with thyroid hormone during tadpole metamorphosis. Gen Comp Endocrinol. 2010;168:209–219.
3. Metzger RJ, Klein OD, Martin GR, Krasnow MA. The branching programme of mouse lung development. Nature. 2008;453:745–750.
4. Pei L, Leblanc M, Barish G, et al. Thyroid hormone receptor repression is linked to type I pneumocyte-associated respiratory distress syndrome. Nat Med. 2011;17:1466–1472.
5. Smith BT, Sabry K. Glucocorticoid-thyroid synergism in lung maturation: a mechanism involving epithelial-mesenchymal interaction. Proc Natl Acad Sci USA. 1983;80:1951–1954.
6. McDonald MC, Henning SJ. Synergistic effects of thyroxine and dexamethasone on enzyme ontogeny in rat small intestine. Pediatr Res. 1992;32:306–311.
7. Amiel-Tison C, Cabrol D, Denver R, Jarreau PH, Papiernik E, Piazza PV. Fetal adaptation to stress. Part I: acceleration of fetal maturation and earlier birth triggered by placental insufficiency in humans. Early Hum Dev. 2004;78:15–27.
8. Challis JR, Sloboda D, Matthews SG, et al. The fetal placental hypothalamic-pituitary-adrenal (HPA) axis, parturition and post natal health. Mol Cell Endocrinol. 2001;185:135–144.
9. Porterfield SP, Hendrich CE. The role of thyroid hormones in prenatal and neonatal neurological development–current perspectives. Endocr Rev. 1993;14:94–106.
10. Welberg LA, Seckl JR. Prenatal stress, glucocorticoids and the programming of the brain. J Neuroendocrinol. 2001;13:113–128.
11. Ing H, O’Malley BW. The Steroid Hormone Receptor Superfamily: Molecular Mechanisms of Action. New York, NY: Raven Press, Ltd; 1995.
12. Courey AJ. Cooperativity in transcriptional control. Curr Biol. 2001;11:R250–R252.
13. Gil-Ibanez P, Bernal J, Morte B. Thyroid hormone regulation of gene expression in primary cerebrocortical cells: role of thyroid hormone receptor subtypes and interactions with retinoic acid and glucocorticoids. PLoS One. 2014;9:e91692.
14. Bagamasbad P, Denver RJ. Thyroid hormone and glucocorticoids synergistically activate transcription of the basic transcription element binding protein 1 gene. Proceedings of the Endocrine Society Annual Meeting, San Francisco, CA, 2008.
15. Bonett RM, Hu F, Bagamasbad P, Denver RJ. Stressor and gluco-corticoid-dependent induction of the immediate early gene kruppel-like factor 9: implications for neural development and plasticity. Endocrinology. 2009;150:1757–1765.
16. Denver RJ, Ouellet L, Furling D, Kobayashi A, Fujii-Kuriyama Y, Puymirat J. Basic transcription element-binding protein (BTEB) is a thyroid hormone-regulated gene in the developing central nervous system. Evidence for a role in neurite outgrowth. J Biol Chem. 1999;274:23128–23134.
17. Denver RJ, Williamson KE. Identification of a thyroid hormone response element in the mouse Kruppel-like factor 9 gene to explain its postnatal expression in the brain. Endocrinology. 2009;150: 3935–3943.
18. Bagamasbad P, Ziera T, Borden SA, et al. Molecular basis for glucocorticoid induction of the Kruppel-like factor 9 gene in hip-pocampal neurons. Endocrinology. 2012;153:5334–5345.
19. Chatonnet F, Guyot R, Benoît G, Flamant F. Genome-wide analysis of thyroid hormone receptors shared and specific functions in neural cells. Proc Natl Acad Sci USA. 2013;110:E766–E775.
20. Datson NA, Polman JA, de Jonge RT, et al. Specific regulatory motifs predict glucocorticoid responsiveness of hippocampal gene expression. Endocrinology. 2011;152:3749–3757.
21. Spörl F, Korge S, Jürchott K, et al. Krüppel-like factor 9 is a circa-dian transcription factor in human epidermis that controls proliferation of keratinocytes. Proc Natl Acad Sci USA. 2012;109: 10903-10908.
22. Denver RJ, Pavgi S, Shi YB. Thyroid hormone-dependent gene expression program for Xenopus neural development. J Biol Chem. 1997;272:8179-8188.
23. Furlow JD, Kanamori A. The transcription factor basic transcription element-binding protein 1 is a direct thyroid hormone response gene in the frog Xenopus laevis. Endocrinology. 2002;143:3295-3305.
24. Hoopfer ED, Huang LY, Denver RJ. Basic transcription element binding protein is a thyroid hormone-regulated transcription factor expressed during metamorphosis in Xenopus laevis. Dev Growth Diff. 2002;44:365-381.
25. Knoedler JR, Denver RJ. Krüppel-like factors are effectors of nuclear receptor signaling. Gen Comp Endocrinol. 2014;203:49-59.
26. Avci HX, Lebrun C, Wehrlé R, et al. Thyroid hormone triggers the developmental loss of axonal regenerative capacity via thyroid hormone receptor a1 and krüppel-like factor 9 in Purkinje cells. Proc Natl Acad Sci USA. 2012;109:14206-14211.
27. Cayrou C, Denver RJ, Puymirat J. Suppression of the basic transcription element-binding protein in brain neuronal cultures inhibits thyroid hormone-induced neurite branching. Endocrinology. 2002;143:2242-2249.
28. Dugas JC, Ibrahim A, Barres BA. The T3-induced gene KLF9 regulates oligodendrocyte differentiation and myelin regeneration. Mol Cell Neurosci. 2012;50:45-57.
29. Lebrun C, Avci HX, Wehrlé R, et al. Klf9 is necessary and sufficient for Purkinje cell survival in organotypic culture. Mol Cell Neurosci. 2013;54:9-21.
30. Moore DL, Blackmore MG, Hu Y, et al. KLF family members regulate intrinsic axon regeneration ability. Science. 2009;326: 298-301.
31. Morita M, Kobayashi A, Yamashita T, et al. Functional analysis of basic transcription element binding protein by gene targeting technology. Mol Cell Biol. 2003;23:2489-2500.
32. Scobie KN, Hall BJ, Wilke SA, et al. Krüppel-like factor 9 is necessary for late-phase neuronal maturation in the developing dentate gyrus and during adult hippocampal neurogenesis. J Neurosci. 2009;29:9875-9887.
33. Nieuwkoop PD, Faber J. Normal Table of Xenopus laevis (Dau-din). New York, NY: Garland Publishing, Inc; 1994.
34. Manzon RG, Denver RJ. Regulation of pituitary thyrotropin gene expression during Xenopus metamorphosis: negative feedback is functional throughout metamorphosis. J Endocrinol. 2004;182: 273-285.
35. Samuels HH, Stanley F, Casanova J. Depletion of L-3,5,3'-triiodo-thyronine and L-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone. Endocrinology. 1979;105:80-85.
36. Yao M, Schulkin J, Denver RJ. Evolutionarily conserved glucocorticoid regulation of corticotropin-releasing factor expression. Endocrinology. 2008;149:2352-2360.
37. Morimoto BH, Koshland DE Jr. Induction and expression of long-and short-term neurosecretory potentiation in a neural cell line. Neuron. 1990;5:875-880.
38. Morimoto BH, Koshland DE Jr. Excitatory amino acid uptake and N-methyl-D-aspartate-mediated secretion in a neural cell line. Proc Natl Acad Sci USA. 1990;87:3518-3521.
39. Maher P, Davis JB. The role of monoamine metabolism in oxidative glutamate toxicity. J Neurosci. 1996;16:6394-6401.
40. Sagara Y, Dargusch R, Chambers D, Davis J, Schubert D, Maher P. Cellular mechanisms of resistance to chronic oxidative stress. Free Radic Biol Med. 1998;24:1375-1389.
41. Sachs LM, Shi YB. Targeted chromatin binding and histone acety-lation in vivo by thyroid hormone receptor during amphibian development. Proc Natl Acad Sci USA. 2000;97:13138-13143.
42. Sachs LM, Jones PL, Havis E, Rouse N, Demeneix BA, Shi YB. Nuclear receptor corepressor recruitment by unliganded thyroid hormone receptor in gene repression during Xenopus laevis development. Mol Cell Biol. 2002;22:8527-8538.
43. Buchholz DR, Paul BD, Shi YB. Gene-specific changes in promoter occupancy by thyroid hormone receptor during frog metamorphosis. Implications for developmental gene regulation. J Biol Chem. 2005;280:41222-41228.
44. Decherf S, Seugnet I, Kouidhi S, Lopez-Juarez A, Clerget-Froidevaux MS, Demeneix BA. Thyroid hormone exerts negative feedback on hypothalamic type 4 melanocortin receptor expression. Proc Natl Acad Sci USA. 2010;107:4471-4476.
45. Fullwood MJ, Ruan Y. ChIP-based methods for the identification of long-range chromatin interactions. J Cell Biochem. 2009;107: 30-39.
46. Goh Y, Fullwood MJ, Poh HM, et al. Chromatin interaction analysis with paired-end tag sequencing (ChIA-PET) for mapping chromatin interactions and understanding transcription regulation. J Vis Exp. 2012;(62).p:3770.
47. Bilesimo P, Jolivet P, Alfama G, et al. Specific histone lysine 4 methylation patterns define TR-binding capacity and differentiate direct T3 responses. Mol Endocrinol. 2011;25:225–237.
48. Fullwood MJ, Liu MH, Pan YF, et al. An oestrogen-receptor-a-bound human chromatin interactome. Nature. 2009;462:58-64.
49. Fullwood MJ, Wei CL, Liu ET, Ruan Y. Next-generation DNA sequencing of paired-end tags (PET) for transcriptome and genome analyses. Genome Res. 2009;19:521-532.
50. Hagège H, Klous P, Braem C, et al. Quantitative analysis of chromosome conformation capture assays (3C-qPCR). Nat Protoc. 2007;2:1722-1733.
51. Furlow JD, Brown DD. In vitro and in vivo analysis of the regulation of a transcription factor gene by thyroid hormone during Xenopus laevis metamorphosis. Mol Endocrinol. 1999;13:2076-2089.
52. Phatnani HP, Greenleaf AL. Phosphorylation and functions of the RNA polymerase II CTD. Genes Dev. 2006;20:2922-2936.
53. Shandilya J, Roberts SG. The transcription cycle in eukaryotes: from productive initiation to RNA polymerase II recycling. Biochim Biophys Acta. 2012;1819:391-400.
54. ENSEMBLE. lincRNA at human Klf9 KSM. Ensembl release 79, March 2015. Accession No. MGI:1915498. Available at http://useast.ensembl.org/Mus_musculus/Gene/Summary?g=ENSMUSG00000044387;r =19:23134900-23135717; t=ENSMUST00000142712.
55. Li G, Fullwood MJ, Xu H, et al. ChIA-PET tool for comprehensive chromatin interaction analysis with paired-end tag sequencing. Genome Biol. 2010;11:R22.
56. Heintzman ND, Hon GC, Hawkins RD, et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature. 2009;459:108-112.
57. Kagey MH, Newman JJ, Bilodeau S, et al. Mediator and cohesin connect gene expression and chromatin architecture. Nature. 2010; 467:430-435.
58. Park SW, Li G, Lin YP, et al. Thyroid hormone-induced juxtaposition of regulatory elements/factors and chromatin remodeling of Crabp1 dependent on MED1/TRAP220. Mol Cell. 2005;19:643-653.
59. Lai F, Orom UA, Cesaroni M, et al. Activating RNAs associate with mediator to enhance chromatin architecture and transcription. Nature. 2013;494:497-501.
60. Ito M, Roeder RG. The TRAP/SMCC/mediator complex and thyroid hormone receptor function. Trends Endocrinol Metab. 2001; 12:127-134.
61. Chen W, Roeder RG. The mediator subunit MED1/TRAP220 is required for optimal glucocorticoid receptor-mediated transcription activation. Nucleic Acids Res. 2007;35:6161-6169.
62. Hittelman AB, Burakov D, Iñiguez-Lluhi JA, Freedman LP, Gara-bedian MJ. Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins. EMBO J. 1999; 18:5380-5388.
63. Carey M. The enhanceosome and transcriptional synergy. Cell. 1998;92:5-8.
64. Herschlag D, Johnson FB. Synergism in transcriptional activation: a kinetic view. Genes Dev. 1993;7:173-179.
65. Malik S, Roeder RG. The metazoan mediator co-activator complex as an integrative hub for transcriptional regulation. Nat Rev Genet. 2010;11:761-772.
66. Whyte WA, Orlando DA, Hnisz D, et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell. 2013;153:307-319.
67. Kulkarni SS, Buchholz D. Beyond synergy: corticosterone and thyroid hormone have numerous interaction effects on gene regulation in Xenopus tropicalis tadpoles. Endocrinology. 2012;153:5309-5324.
68. Bejerano G, Pheasant M, Makunin I, et al. Ultraconserved elements in the human genome. Science. 2004;304:1321-1325.
69. Faircloth BC, McCormack JE, Harvey MG, et al. Ultra Conserved Elements. Available at http://ultraconserved.org/.
70. Katzman S, Kern AD, Bejerano G, et al. Human genome ultraconserved elements are ultraselected. Science. 2007;317:915-915.
71. Vallabhapurapu S, Karin M. Regulation and function of NF-kB transcription factors in the immune system. Annu Rev Immunol. 2009;27:693-733.
72. Contreras-Jurado C, García-Serrano L, Gómez-Ferrería M, Costa C, Paramio JM, Aranda A. The thyroid hormone receptors as modulators of skin proliferation and inflammation. J Biol Chem. 2011; 286:24079-24088.
73. Lasa M, Gil-Araujo B, Palafox M, Aranda A. Thyroid hormone antagonizes tumor necrosis factor-a signaling in pituitary cells through the induction of dual specificity phosphatase 1. Mol Endocrinol. 2010;24:412-422.
74. Huffman LJ, Prugh DJ, Brumbaugh K, Ding M. Influence of hyperthyroidism on rat lung cytokine production and nuclear factor-K B activation following ozone exposure. Inhal Toxicol. 2002;14: 1161-1174.
75. Nandakumar DN, Koner BC, Vinayagamoorthi R, et al. Activation of NF-k B in lymphocytes and increase in serum immunoglobulin in hyperthyroidism: possible role of oxidative stress. Immunobiology. 2008;213:409-415.
76. Aoyagi S, Archer TK. Dynamics of coactivator recruitment and chromatin modifications during nuclear receptor mediated transcription. Mol Cell Endocrinol. 2008;280:1-5.
77. Luebben WR, Sharma N, Nyborg JK. Nucleosome eviction and activated transcription require p300 acetylation of histone H3 lysine 14. Proc Natl Acad Sci USA. 2010;107:19254-19259.
78. Natoli G, Andrau JC. Noncoding transcription at enhancers: general principles and functional models. Annu Rev Genet. 2012;46: 1-19.
79. De Santa F, Barozzi I, Mietton F, et al. A large fraction of extragenic RNA Pol II transcription sites overlap enhancers. PLoS Biol. 2010; 8:e1000384.
80. Heintzman ND, Stuart RK, Hon G, et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet. 2007;39:311-318.
81. Kim TK, Hemberg M, Gray JM, et al. Widespread transcription at neuronal activity-regulated enhancers. Nature. 2010;465:182-187.
82. Koch F, Fenouil R, Gut M, et al. Transcription initiation platforms and GTF recruitment at tissue-specific enhancers and promoters. Nat Struct Mol Biol. 2011;18:956-963.
83. Ørom UA, Shiekhattar R. Long noncoding RNAs usher in a new era in the biology of enhancers. Cell. 2013;154:1190-1193.
84. Szutorisz H, Dillon N, Tora L. The role of enhancers as centres for general transcription factor recruitment. Trends Biochem Sci. 2005;30:593-599.
85. Ponjavic J, Oliver PL, Lunter G, Ponting CP. Genomic and transcriptional co-localization of protein-coding and long non-coding RNApairs in the developing brain. PLoS Genet. 2009;5:e1000617.
86. Ørom UA, Derrien T, Beringer M, et al. Long noncoding RNAs with enhancer-like function in human cells. Cell. 2010;143:46-58.
87. Li W, Notani D, Ma Q, et al. Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation. Nature. 2013;498: 516-520.
88. Bagamasbad P, Denver RJ. Mechanisms and significance of nuclear receptor auto- and cross-regulation. Gen Comp Endocrinol. 2011; 170:3-17.
89. Brüggemeier U, Rogge L, Winnacker EL, Beato M. Nuclear factor I acts as a transcription factor on the MMTV promoter but competes with steroid hormone receptors for DNA binding. EMBO J. 1990;9:2233-2239.
90. Wyszomierski SL, Rosen JM. Cooperative effects of STAT5 (signal transducer and activator of transcription 5) and C/EBP/3 (CCAAT/ enhancer-binding protein-/3) on /3-casein gene transcription are mediated by the glucocorticoid receptor. Mol Endocrinol. 2001;15: 228-240.
91. Hebbar PB, Archer TK. Chromatin-dependent cooperativity between site-specific transcription factors in vivo. J Biol Chem. 2007; 282:8284-8291.
92. Gummow BM, Scheys JO, Cancelli VR, Hammer GD. Reciprocal regulation of a glucocorticoid receptor-steroidogenic factor-1 transcription complex on the Dax-1 promoter by glucocorticoids and adrenocorticotropic hormone in the adrenal cortex. Mol Endocrinol. 2006;20:2711-2723.
93. Takeda T, Kurachi H, Yamamoto T, et al. Crosstalk between the interleukin-6 (IL-6)-JAK-STAT and the glucocorticoid-nuclear receptor pathway: synergistic activation of IL-6 response element by IL-6 and glucocorticoid. J Endocrinol. 1998;159:323-330.
94. Lerner L, Henriksen MA, Zhang X, Darnell JE Jr. STAT3-depen-dent enhanceosome assembly and disassembly: synergy with GR for full transcriptional increase of the a 2-macroglobulin gene. Genes Dev. 2003;17:2564-2577.
95. Latchoumanin O, Mynard V, Devin-Leclerc J, Dugué MA, Bertagna X, Catelli MG. Reversal of glucocorticoids-dependent proopiomelanocortin gene inhibition by leukemia inhibitory factor. Endocrinology. 2007;148:422-432.
96. Tan SH, Dagvadorj A, Shen F, et al. Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells. Cancer Res. 2008;68:236-248.
97. Kabotyanski EB, Huetter M, Xian W, Rijnkels M, Rosen JM. Integration of prolactin and glucocorticoid signaling at the /3-casein promoter and enhancer by ordered recruitment of specific transcription factors and chromatin modifiers. Mol Endocrinol. 2006; 20:2355-2368.
98. Ong CT, Corces VG. Enhancer function: new insights into the regulation of tissue-specific gene expression. Nat Rev Genet. 2011; 12:283-293.
99. Cheng SY, Leonard JL, Davis PJ. Molecular aspects of thyroid hormone actions. Endocr Rev. 2010;31:139-170.
100. Shi YB. Unliganded thyroid hormone receptor regulates metamor-phic timing via the recruitment of histone deacetylase complexes. Curr Top Dev Biol. 2013;105:275-297.
101. Ruan X, Ruan Y. Genome wide full-length transcript analysis using 5' and 3' paired-end-tag next generation sequencing (RNA-PET). Methods Mol Biol. 2012;809:535-562.